Bill Ackman Backs Mark Cuban's Drug Pricing Model: These Healthcare Stocks Could Win—Or Lose
Bill Ackman backed Mark Cuban's drug pricing model. Here's which healthcare stocks could benefit—and which face pressure.
Stocks · News reference
Snap To Rally More Than 217%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed outlook on top names. Complete view of analyst rating changes, including upgrades/downgrades, on analyst ratings page.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
FDA Says It Has Received 990 Adverse Event Reports Tied To Compounded Semaglutide And More Than 730 Tied To Compounded Tirzepatide; Establishes Import Alert For Compounded GLP-1 Active Pharmaceutical Ingredients
Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today
The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.
Can Cigna's Smart Coverage Help Close Health-Cost Gaps?
Cigna Healthcare is introducing Smart Coverage, a new benefit option that automatically links medical claims with supplemental benefits to provide eligible members up to $7,000 for covered health events. The program launches January 1, 2027, for mid-sized employers and addresses a significant affordability gap, with nearly 60% of Americans unprepared for health costs. The initiative is designed to increase enrollment in high-deductible plans and boost supplemental product participation.
Benzinga Bulls and Bears: Palo Alto, Ciena, Lululemon
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
Shares of software companies are trading higher amid sympathy with Snowflake after the company reported better-than-expected Q2 financial results, boosting sentiment across the sector. Falling Treasury yields and Fed's Waller's comments that he is inclined to support holding interest rates steady may also be supporting growth stocks by easing concerns about tighter monetary policy and improving risk appetite.